Verseau Therapeutics

Discovering and developing novel cancer treatments

placeLexington, Massachusetts, United States calendar_todayFounded 2017 groups12 employees language verseautx.com

Registered entities

Innovation

7 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 600 times.

YearFilings
20206
20215
20227
20235
20241
20251
20261

Investor mix

6 investors on record; lead investors include 3SBio, 20/20 HealthCare Partners, Alexandria, Highlight Capital.

Investor typeCountShare
Venture capital233%
Private equity117%
Other / undisclosed350%
Coming soon